Tumour necrosis factor-α/etanercept complexes in serum predict long-term efficacy of etanercept treatment in seronegative rheumatoid arthritis

E. Berthold, B. Månsson, B. Gullstrand, P. Geborek, T. Saxne, A. Bengtsson, R. Kahn

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Tumour necrosis factor-α/etanercept complexes in serum predict long-term efficacy of etanercept treatment in seronegative rheumatoid arthritis'. Together they form a unique fingerprint.

Medicine & Life Sciences